ABSTRACT Cell-penetrating peptides are able to transport covalently attached cargoes such as peptide or polypeptide fragments of endogenous proteins across cell membranes. Taking advantage of the cell-penetrating properties of the 16-residue fragment penetratin, we synthesized a chimeric peptide that possesses an N-terminal sequence with membrane-penetrating activity and a C-terminal sequence corresponding to the last 21 residues of G␣ s . This G␣ s peptide was an effective inhibitor of 5Ј-N-ethylcarboxamidoadenosine (NECA) and isoproterenolstimulated production of cAMP in rat PC12 and human microvascular endothelial (HMEC-1) cells, whereas the carrier peptide had no effect. The maximal efficacy of NECA was substantially reduced when PC12 cells were treated with the chimeric peptide, suggesting that it competes with G␣ s for interaction with receptors. The peptide inhibited neither G q -nor G i -coupled receptor signaling. The use of a carboxy-fluorescein derivative of the peptide proved its ability to cross the plasma membrane of live cells. NMR analysis of the chimeric peptide structure in a membrane-mimicking environment showed that the G␣ s fragment assumed an amphipathic ␣-helical conformation tailored to make contact with key residues on the intracellular side of the receptor. The N-terminal penetratin portion of the molecule also showed an ␣-helical structure, but hydrophobic and hydrophilic residues formed clustered surfaces at the N terminus and center of the fragment, suggesting their involvement in the mechanism of penetratin internalization by endocytosis. Our biological data supported by NMR analysis indicate that the membrane-permeable G␣ s peptide is a valuable, nontoxic research tool to modulate G s -coupled receptor signal transduction in cell culture models.
G i -coupled receptor signaling. The use of a carboxy-fluorescein derivative of the peptide proved its ability to cross the plasma membrane of live cells. NMR analysis of the chimeric peptide structure in a membrane-mimicking environment showed that the G␣ s fragment assumed an amphipathic ␣-helical conformation tailored to make contact with key residues on the intracellular side of the receptor. The N-terminal penetratin portion of the molecule also showed an ␣-helical structure, but hydrophobic and hydrophilic residues formed clustered surfaces at the N terminus and center of the fragment, suggesting their involvement in the mechanism of penetratin internalization by endocytosis. Our biological data supported by NMR analysis indicate that the membrane-permeable G␣ s peptide is a valuable, nontoxic research tool to modulate G s -coupled receptor signal transduction in cell culture models.
G protein-coupled receptors (GPCRs) represent a large family of cell-surface receptors sharing a common transmembrane structure and signal transduction mechanisms. The basic unit of GPCR signaling is composed of a heptahelical receptor, a heterotrimeric GTP-binding protein (G protein) , and an effector, such as an enzyme or an anion channel. The binding of an agonist ligand to the GPCR changes its conformation to allow productive coupling with its cognate G protein, leading to the exchange of GTP for GDP on the G␣ subunit and consequent dissociation of G␣-GTP from the G␤␥ complex.
Multiple sites of interaction cooperate in the physical coupling between the activated receptor and the G protein . Data from crystallographic, biochemical, and mutagenesis studies indicate that the key elements of the interaction are primarily the second and third intracellular loops of the receptor making physical contact with the C terminus of the G␣ subunit (Kobilka et al., 1988; Kostenis et al., 1997) . The last ϳ50 residues of the G␣ subunits play a central role in discriminating between different receptor subtypes or different functional states of the same receptor Havlickova et al., 2003; Slessareva et al., 2003) .
Pharmacological agents that act as agonists or antagonists of GPCRs are the most common type of drug in clinical use today. Irrespective of their chemical structure, all of these agents have a common mechanism of action in that they act extracellularly either to mimic or to preclude agonist binding to its receptor. As an alternative approach to antagonism of GPCR signaling, the receptor-G protein interface can be targeted with agents that block coupling between the receptor and the G protein intracellularly. Such an approach is expected to produce G protein-specific rather than receptorspecific antagonism. This strategy has produced several successful results using polypeptides derived from either the putative contact surface on the receptor or the G␣ subunit (Freissmuth et al., 1999) .
In intact cells, membrane-permeable peptides containing the C-terminal sequence of G␣ q and G␣ s disrupt 5-hydroxytryptamine 2c and ␤ 2 -adrenergic receptor-mediated activation of phospholipase C-␤ and adenylyl cyclase, respectively (Chang et al., 2000) . Cellular expression of a 83-residue polypeptide derived from the C terminus of G␣ s inhibits ␤ 2 -adrenergic and dopamine D 1A receptor-mediated cAMP production (Feldman et al., 2002) . Minigene plasmids encoding oligopeptides representing the last 11 C-terminal residues of G␣ i , G␣ o , G␣ q , G␣ 12 , and G␣ 13 have been successfully used to discern the contribution of different G proteins to signaling by M 2 muscarinic and thrombin receptors (Gilchrist et al., 1999; Vanhauwe et al., 2002) .
In a previous article (Mazzoni et al., 2000) , we showed that a 21-residue synthetic peptide, G␣ s (374 -394)C 379 A, derived from rat G␣ s C terminus inhibits A 2A adenosine receptormediated activation of adenylyl cyclase in rat striatal membranes, and it acquires a defined helical conformation in solution. Here, we present both biological and structural data of a membrane-permeable synthetic peptide containing the sequence of the G␣ s (374 -394)C 379 A peptide on the C-terminal side. This membrane-permeable peptide was designed using as carrier molecule, penetratin, a 16-residue fragment derived from the homeodomain of the Drosophila melanogaster transcription factor Antennapedia that translocates through biological membranes (Derossi et al., 1994) . The membrane-permeable 37-residue peptide (dubbed A42) was able to cross HMEC-1 and PC12 cell plasma membrane inhibiting A 2A , A 2B adenosine, and ␤-adrenergic receptor-stimulated cAMP production without affecting G q -and G i -coupled receptor signaling. Structural data indicated the molecular basis of A42 tropism for plasma membrane. According to previous conformational studies of isolated penetratin (Lindberg et al., 2001) and G␣ s fragments (Mazzoni et al., 2000) , both A42 segments were arranged in ␣-helical structures so that the presence of one did not affect the conformation and functionality of the other. Our synthetic peptide represents a powerful tool to inhibit G s -coupled receptor signaling in intact cells.
Materials and Methods
Adenosine deaminase was obtained from Roche Molecular Biochemicals (Mannheim, Germany). Fetal bovine serum (FBS) was from Cambrex Corporation (East Rutherford, NJ). MCDB 131 medium was purchased from Invitrogen (Carlsbad, CA). Kaighn's modified Ham's F12 medium (F12K), penicillin, streptomycin, horse serum, papaverine, 5Ј-N-ethylcarboxamidoadenosine (NECA), isoproterenol, forskolin, and direct cAMP enzyme immunoassay kit (CA-200) were products of Sigma-Aldrich (St. Louis, MO). 2,4-Difluoro-␣-␣ 1 -bis(1H-1,2,4 -triazol-1ylmethyl)benzyl alcohol (fluconazole) was a product of Pfizer Inc. (New York, NY). All other reagents were from standard commercial sources and were of the highest grade available.
Cell Culture. PC12 cells obtained from the American Type Culture Collection (Manassas, VA) were maintained in F12K medium supplemented with 15% horse serum, 2.5% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, and 0.02 mg/ml fluconazole in an atmosphere of 95% air/5% CO 2 at 37°C. Cells were recultivated two to three times per week. A human dermal microvascular endothelial cell line that was transformed using SV-40 was also used (HMEC-1; obtained from Dr. E. Ades, Centers for Disease Control and Prevention, Atlanta, GA). Cells were maintained in MCDB 131 medium supplemented with 5% FBS, penicillin/streptomycin (5000 units/ml and 5000 g/ml, respectively), hydrocortisone (500 g/ml), epidermal growth factor (0.01 g/ml), and L-glutamine (2 mM) at 37°C as above. Cells were seeded at 1 ϫ 10 5 cells/ml and were subcultured at confluence. In our studies, cells were used at passages 18 to 24.
To determine the number of viable PC12 cells in proliferation, a colorimetric assay was used (CellTiter 96 AQ ueous One Solution Cell Proliferation Assay; Promega, Madison, WI). PC12 cells were seeded in a 96-well plate (6 ϫ 10 3 cells/well) and maintained in culture for 48 h, changing medium after 24 h. The A42 peptide was added at a final concentration of 300 M and incubated for 30 min at 37°C. At the end of this period, the CellTiter 96 AQ ueous One Solution Reagent was added according to the manufacturer's instructions, and the plate was incubated in the dark for 2 h at 37°C. Absorbance was recorded at 490 nm using a Wallac 1420 multilabel counter (PerkinElmer Wallac, Boston, MA).
To obtain PC12 differentiation into sympathetic-like neurons, cells were seeded in eight-well poly(D-lysine)-coated culture slides (3000 cells/well) and cultured in the presence of 100 ng/ml fibroblast growth factor for 5 days. The culture medium containing fibroblast growth factor was replaced every 2 days. Before treatment with the fluorescein-labeled peptide, cells were rinsed twice with 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.4, 136.8 mM NaCl, 2.7 mM KCl (PBS) containing 0.5 mM MgCl 2 , and 0.6 mM CaCl 2 (Dulbecco's PBS) and then were incubated in serum-free F12K medium containing 1 mg/ml bovine serum albumin in the presence and absence of 100 M fluorescent A42 peptide for 30 min, 3 h, and 6 h. At the end of the incubation times, cells were rinsed twice with Dulbecco's PBS and treated with the Image-iT-Live Plasma Membrane and Nuclear Labeling Kit (Molecular Probes, Carlsbad, CA) according to the manufacturer's instruction. Fluorescent specimens were viewed using a Zeiss Axioskop microscope (Carl Zeiss GmbH, Jena, Germany). Digital images were taken with a Leica DC100 camera (Leica, Wetzlar, Germany). The brightness and the contrast of the final images were adjusted using Adobe Photoshop version 6.00 (Adobe Systems, Mountain View, CA).
Peptide Synthesis. Peptides were synthesized manually, using a conventional solid-phase strategy based on the Fmoc/t-Bu protection chemistry. The crude products were purified to homogeneity by semipreparative high-performance liquid chromatography. The final peptides were characterized by analytical high-performance liquid chromatography (purity, Ͼ98%) and mass spectrometry. Peptide sequences were as follows: H-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-AsnArg-Arg-Met-Lys-Trp-Lys-Lys for the carrier peptide (A40) and HArg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Arg-Val-Phe-Asn-Asp-Ala-Arg-Asp-Ile-Ile-Gln-Arg-Met-HisLeu-Arg-Gln-Tyr-Glu-Leu-Leu-OH (A42) for the membranepermeable G␣ s peptide (the G␣ s C-terminal sequence is underlined). A fluorescent analog of A42 was prepared by EspiKem (Florence, Italy), linking carboxy-fluorescein to the peptide N terminus, spaced by a residue of -aminobutyric acid.
Peptides were dissolved in water to obtain 2 mM stock solutions. All peptide stock solutions were centrifuged at 11,000g for 4 min at room temperature, and supernatants were collected. The concentration of the membrane-permeable G␣ s peptide was roughly estimated spectrophotometrically using the molar extinction coefficient for tyrosine at 280 nm (⑀ 280nm ϭ 1400 M Ϫ1 ⅐ cm
Ϫ1
), as reported previously (Mazzoni et al., 2000) .
Measurement of Intracellular cAMP. To study receptor-mediated cAMP accumulation, PC12 (passages 6-18) or HMEC-1 cells (passage 18-24) were seeded in 24-well culture plates at a density of approximately 6 ϫ 10 4 or 1 ϫ 10 5 cells/well and were used just after reaching confluence. Cells were preincubated in the presence of 100 M papaverine with and without 1 U/ml of adenosine deaminase in F12K or MCDB 131 medium for 30 min at 37°C. Assays were initiated by the addition of 1 M (PC12), 5 M (HMEC-1) NECA, or 1 M (HMEC-1) isoproterenol, followed by the incubation for 15 min at 37°C. Peptides (A40 or A42) were added 30 min before assay initiation, together with papaverine. At the end of the incubation time, the reaction was terminated by the removal of the reaction medium, followed immediately by the addition of 0.3 ml of 0.1 N HCl. The HCl extracts were collected into 15-ml Falcon tubes, and cells were rinsed with an additional 0.3 ml of 0.1 N HCl. Samples of the pooled HCl extract were centrifuged at 600g for 10 min. Aliquots (100 l) of the supernatant were processed to measure cAMP content using the direct cAMP enzyme immunoassay kit from Sigma-Aldrich.
The effect of A42 on the concentration-response curve of NECA (0.1 nM to 5 M) was evaluated by preincubating PC12 cells in the presence and absence of 10, 50, and 100 M A42. The concentrationdependent effect of A42 was evaluated by preincubating PC12 cells with 11 different concentrations of the peptide ranging from 0.05 to 560 M.
To study the effect of the membrane-permeable G␣ s peptide on adenylyl cyclase and G i signaling, PC12 cells were preincubated in the presence of 100 M papaverine with and without 100 M A42 in F12K medium for 30 min at 37°C. At the end of the preincubation period, either 10 M forskolin, 1 M ADP␤S (P2y 12 receptor agonist), or both were added and incubated for 15 min at 37°C. Thereafter, the incubation medium was removed, 0.1 N HCl was added, and samples were processed as described above.
Measurement of Intracellular Calcium. Measurement of [Ca 2ϩ ] i was performed as described previously (Ceccarelli et al., 2003) . In brief, confluent PC12 cells cultured in 24-well plates were incubated with and without 100 M A42 in loading buffer (20 mM HEPES, pH 7.4, 130 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 0.8 mM Na 2 HPO 4 , 0.2 mM NaH 2 PO 4 , 25 mM mannose, and 1 mg/ml bovine serum albumin) containing 2 M Fluo-3 acetoxymethyl ester and 0.008% Pluronic F-127 for 30 min at 37°C. After incubation, cells were rinsed with detaching buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM KCl, 0.55 mM MgCl 2 , and 3 mM EDTA) and incubated in the same buffer for 10 min at 37°C. Detached cells were harvested by low-speed centrifugation (1000g), resuspended in assay buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM KCl, 0.55 mM MgCl 2 , and 1 mM CaCl 2 ), and analyzed on a FACScan flow cytometer with the CellQuest software (Becton Dickinson Labware; BD Biosciences, San Jose, CA).
To study receptor-mediated increase of [Ca 2ϩ ] i , sample basal fluorescence was measured, and then 100 M ATP␥S (P2y 2 receptor agonist) was added. The cell flow was halted during this addition, and sample measurement was carried out within 2 to 3 s.
Data Analysis. Data from concentration-response curves were analyzed by a least-squares curve-fitting computer program (GraphPad Prism version 4.00 for Windows; GraphPad Software, San Diego, CA), and EC 50 values were determined. Values represent the means Ϯ S.E.M. of at least three independent experiments. The statistical significance of value differences was evaluated by the unpaired Student's t test using GraphPad Prism version 4.00.
NMR Spectroscopy. Samples for NMR spectroscopy were prepared by dissolving the appropriate amount of A42 in a water/SDS (SDS-d 25 ) solution, pH 6.6, to obtain concentrations of 2 mM peptide and 80 mM SDS-d 25 . Dodecyl phosphocholine samples were prepared by dissolving the appropriate amount of A42 in water/dodecyl phosphocholine (DPC-d 38 ), pH 5.8, to obtain concentrations of 2 mM peptide and 15 mM DPC-d 38 . NMR spectra were recorded on a Bruker DRX-600 spectrometer (Bruker, Newark, DE). One-dimensional NMR spectra were recorded in the Fourier mode with quadrature detection, and the water signal was suppressed by a low-power selective irradiation in the homogated mode. DQF-COSY (Piantini et al., 1982) , TOCSY (Braunschweiler and Ernst, 1983; Bax and Davis, 1985) , and NOESY (Jeener et al., 1979; Macura and Ernst, 1980) experiments were run in the phase-sensitive mode using quadrature detection in 1 by time-proportional phase increments of the initial pulse (Marion and Wü htrich, 1983) .
Data block sizes comprised 2048 addresses in t2 and 512 equidistant t1 values. Before Fourier transformation, the time domain data matrices were multiplied by shifted sin2 functions in both dimensions. A mixing time of 70 ms was used for TOCSY experiments. NOESY experiments were run at 300 K, with mixing times in the range of 100 to 250 ms. The qualitative and quantitative analysis of DQF-COSY, TOCSY, and NOESY spectra were obtained using the SPARKY interactive program package (Goddard TD, Kneller DG, SPARKY 3, University of California, San Francisco, San Francisco, CA).
Spin-Label Experiments. NMR samples were prepared by dissolving A42 at a final concentration of 2 mM in 80 mM SDS solution dissolved in H 2 O/D 2 O. Assuming an SDS micelle aggregation number of 56, this corresponds to a micelle concentration of 1.8 mM. The H 2 O/D 2 O ratio was 90:10 (Lauterwein et al., 1979) . The 5-and 16-doxyl stearic acids were solubilized in methanol-d 4 and then added to the samples. Structure Calculation. Peak volumes were translated into upper distance bounds with the routine CALIBA of the DYANA software (Guntert et al., 1997) . The necessary pseudoatom corrections were applied for nonstereospecifically assigned protons at prochiral centers and for the methyl group. After discarding redundant and duplicated constraints, the final list included 411 intraresidue and 125 inter-residue constraints, which were used to generate an ensemble of 200 structures by the standard protocol of simulated annealing in torsion angle space implemented in DYANA. No dihedral angle restraints and no hydrogen bond restraints were applied. The best 50 structures, which showed low values of the target functions (0.83-1.19) and small residual violations (maximum violation ϭ 1.38 Å), were refined by in vacuo minimization using Discover module of MSI Insight II 2000 software, using cvff force field and applying a dielectric constant value of 1*r (MSI Molecular Simulations, San Diego, CA). First, the 50 structures were relaxed and then were constrained and unconstrained by using a combination of steepest descent and conjugate gradient minimization algorithms until the maximum RMS derivative was less than 0.01 kcal/Å. The resulting structures showed a root mean square deviation value of 0.9 Å on C atoms.
The minimum energy structure was subjected to a molecular dynamics procedure on peptide side chains, keeping the backbone geometry fixed. After an equilibration period of 10 ps, during which the temperature was gradually increased from 10 to 300 K, molecular dynamic simulations were run at 300 K for 600 ps. During molecular dynamics frame structures were saved each 10 fs. The final structures were analyzed using the Insight II 2000 program. Computations were performed on an Octane computer (SGI, Mountain View, CA).
Disruption of Receptor Signaling by Cell-Penetrating Peptide

Results
In a previous article, we reported that the ␣-helical conformation of G␣ s C terminus is important to determine its ability to interact with the A 2A adenosine receptor, but this part of the G␣ s molecule is not able to stabilize the highaffinity state of the receptor (Mazzoni et al., 2000; D'Ursi et al., 2002) . Moreover, we have shown that a G␣ s C-terminal 21-residue peptide G␣ s (374 -394)C 379 A disrupts signal transduction and induces a conformational change of the receptor with stabilization of an intermediate affinity state for agonist ligands (Mazzoni et al., 2000) . Now, we have designed and synthesized a 37-residue membrane-permeable peptide, A42, containing a 16-residue fragment (A40) derived from the homeodomain of the D. melanogaster transcription factor Antennapedia on the N-terminal side and G␣ s (374 -394)C 379 A on the C-terminal side. A preliminary screening of cell-permeable peptide influence on PC12 cells demonstrated that preincubation of cell cultures with either 300 M A40 or A42 peptide did not cause cell lysis (data not shown). The membrane-permeable G␣ s peptide did not induce any reduction of cell viability, as shown by no variation of color development after the addition of the CellTiter 96 reagent between control (absorbance at 490 nm, 0.24 Ϯ 0.02; n ϭ 4) and peptide-treated (absorbance at 490 nm, 0.26 Ϯ 0.01; n ϭ 4) cells. The effects of A40 and A42 peptides on basal and adenosine receptor (A 2A and A 2B adenosine receptors)-stimulated cAMP accumulation in intact PC12 cells were evaluated. The addition of either one of the peptides had no significant effect on basal cAMP production (data not shown).
Analysis of A40 and A42 Effects on NECA-Stimulated cAMP Production in PC12 Cells. The effects of various concentrations of A40 or A42 on cAMP accumulation induced by stimulation with 1 M NECA were measured in PC12 cells. The membrane-permeable G␣ s peptide inhibited adenosine receptor-mediated cAMP production in a concentrationdependent manner, whereas the Antennapedia fragment had no major effect (Fig. 1) . Analysis of data using a nonlinear curve-fitting program and statistical comparison of possible fits revealed that the A42 curve was better represented by a sigmoidal dose-response curve with variable slope than a simple sigmoidal dose-response curve (p Ͻ 0.05). The receptor-mediated cAMP production was completely inhibited at an A42 concentration of 560 M, whereas the derived EC 50 value was 5.30 Ϯ 1.20 M (n ϭ 4).
To further characterize the mechanism sustaining A42 pharmacological activity, the effect of three different concentrations of the peptide on cAMP accumulation induced by PC12 stimulation with different concentrations of NECA was examined. Data obtained from stimulating cells with NECA in the absence of the peptide were analyzed and fitted using a nonlinear curve-fitting program (Fig. 2) . Analysis revealed that the concentration-response curve was represented by a simple sigmoidal dose-response curve. The calculated EC 50 value was 63.51 Ϯ 10.50 nM (n ϭ 5), whereas the maximal cAMP production was 296.81 Ϯ 13.79 nM. Addition of 10, 50, or 100 M A42 caused significant reductions of NECA efficacy (Fig. 2) . In fact, at a NECA concentration of 1 M, 10 and 50 M A42 reduced agonist efficacy by 46 and 64%, respectively, compared with control values in the absence of A42 (Fig. 2) . The concentration-response curves obtained in the presence of 10, 50, and 100 M A42 were fitted by a simple sigmoidal dose-response model with EC 50 values of 84.86 Ϯ 29.60 (n ϭ 3), 126.10 Ϯ 28.20 (n ϭ 4), and 104.90 Ϯ 24.50 (n ϭ 3) nM, respectively, indicating that the membrane-permeable G␣ s peptide modulated agonist potency.
Analysis of A42 Specificity for Disrupting G s -Coupled Receptors Signaling. To verify the specificity of the A42 effect at the interface between adenosine receptors and G s , we examined whether the membrane-permeable G␣ s peptide was able to directly inhibit adenylyl cyclase and/or disrupt P2y 12 and P2y 2 receptors coupling to G i and G q proteins, respectively. Both subtypes of P2y receptors are expressed in PC12 cells (Unterberger et al., 2002) , and it is well established that P2y 12 activation leads to the inhibition of adenylyl cyclase, whereas P2y 2 activation induces an increase of [Ca 2ϩ ] i (Ralevic and Burnstock, 1998) . The A42 peptide did not influence forskolin-induced cAMP in intact PC12 cells (Fig. 3) , indicating that had no direct inhibitory effect on adenylyl cyclase. In addition, the peptide did not affect P2y 12 receptor-mediated inhibition of cAMP production (Fig. 3) . Fig. 1 . Concentration-dependent effect of A40 and A42 peptides on NECA-stimulated cAMP production in PC12 cells. PC12 cells were incubated with various concentrations of either A40 or A42 in the presence of 1 M NECA as described under Materials and Methods. Control value in the absence of peptides was 304.12 Ϯ 15.09 nM cAMP (n ϭ 5). Values are the mean Ϯ S.E.M. of three (A40) and five (A42) independent experiments each performed in duplicate. The EC 50 value was determined by fitting data as a sigmoidal dose-response curve with variable slope using GraphPad Prism version 4.00. (Fig. 4) , which was not modulated by the addition of A42. These results indicate that the membrane-permeable G␣ s peptide did not influence the interactions between P2y receptors and G i /G q proteins supporting the specificity of peptide activity.
The ability of A42 to inhibit receptor-mediated cAMP production was also evaluated in HMEC-1, a human microvascular endothelial cell line, which constitutively expresses both A 2A and A 2B adenosine receptors (Feoktistov et al., 2002) and ␤-adrenergic receptors (Gornikiewicz et al., 2000) . In this cell line, A 2B /A 2A mRNA ratio is approximately 4:1 (Feoktistov et al., 2002) , whereas in PC12 cells, although both A 2A and A 2B mRNA were expressed (Arslan et al., 1999) , the A 2A adenosine receptor seems to be the major adenosine receptor subtype involved in NECA-stimulated effector activation in some cellular clones (Arslan et al., 1999) . Indeed, HMEC-1 stimulation with 5 M NECA induced a cAMP production of 102.07 Ϯ 12.44 nM, whereas in PC12 cells, stimulation with the same concentration of NECA caused a cAMP production of 296.80 Ϯ 13.79 nM. The A42 peptide significantly inhibited NECA-stimulated cAMP production in HMEC-1, although the control peptide (A40) had no major inhibitory effect (Fig. 5 ). In addition, A42 inhibited ␤-adrenergic receptor-mediated cAMP production, even though 1 M isoproterenol caused a moderate accumulation of cAMP (51.63 Ϯ 10.84 nM) in HMEC-1.
Analysis of Fluorescent A42 Peptide Internalization. To verify the ability of the A42 peptide to cross cell membranes, we synthesized a carboxy-fluorescein-labeled derivative of such peptide and incubated neuronal differentiated PC12 cells in the presence and absence of a fixed concentration of such fluorescent peptide for various times. Neuronaldifferentiated PC12 cells were preferred over undifferentiated cells because the distribution of the fluorescent membrane-permeable peptide along the neurites can be analyzed. Living cells were labeled with the fluorescent peptide followed by membrane staining with the Image-iTLive Plasma Membrane and Nuclear Labeling Kit. In Fig. 6 , digital images of fluorescent cells are shown. Figure 6 , A and B, illustrates cell labeling with the fluorescein-conjugated A42 peptide (green fluorescence) after 30 min and 3 h of incubation, respectively. At 30 min, the fluorescent peptide was localized on plasma membrane in both cell bodies and neurites, whereas after 3 and 6 h (data not shown), the fluores- ] i in PC12 cells. Confluent PC12 cells cultured in 24-well plates were incubated with and without 100 M A42 in a loading buffer containing 2 M Fluo-3 acetoxymethyl ester and 0.008% Pluronic F-127 for 30 min at 37°C. Cells were detached, harvested, and analyzed on a FACScan flow cytometer as described under Materials and Methods. The basal fluorescence was recorded for each sample, and then the agonist (100 M ATP␥S) was added. The basal [Ca 2ϩ ] i was determined as described previously (Ceccarelli et al., 2003) . Values are the mean Ϯ S.E.M. of three independent experiments each performed in duplicate. (Fig. 6, C and D) .
NMR Spectroscopy. The membrane environment for NMR studies is usually mimicked by surfactant supramolecular aggregates, generally constituted by an apolar inner core and a hydrophilic exposed interface. Although a variety of surfactant supramolecular structures have been proposed for NMR analysis, the choice is limited because of the high costs of the surfactant deuteration and usually low quality of spectra produced in such systems. Micellar solutions of SDS, DPC, and dipalmitoyl phosphatidyl cholin are typically used for NMR investigations (Bader et al., 2003) .
A whole set of one-and two-dimensional protonic spectra were recorded in aqueous solution of 80 mM SDS and 15 mM DPC solution. To check the absence of peptide aggregation states, spectra were acquired within the concentration range of 0.5 to 15 mM. No significant changes were observed in the distribution and shape of the 1 H resonances, indicating that no aggregation phenomena occurred within this concentration range.
Because of the better quality of SDS NMR spectra versus DPC NMR spectra, the complete resonance assignments of A42 were achieved in SDS micellar solution according to the method of Wü thrich (1986) via the usual systematic application of DQF-COSY (Piantini et al., 1982) , TOCSY (Braunschweiler and Ernst, 1983; Bax and Davis, 1985) , and NOESY (Jeener et al., 1979; Macura and Ernst, 1980) experiments with the support of SPARKY software package. The resonances of several CH␣ were shifted up-field, suggesting the involvement of these residues in ␣-helix or in-turn secondary structure (Wishart et al., 1991) . The pattern of NOE connectivities observed in NOESY spectra (data not shown) were consistent with the presence of two helical stretches localized at N and C termini of the A42 peptide. In Figs. 7 and 8 , the N-and C-terminal helices are represented with violet and cyan ribbons, respectively. Low regularity in the dihedral angle patterns was detectable at the level of residues 11 to 17. Structure Calculation. Three-dimensional structures of A42 were calculated by simulated annealing in torsion angle space and restrained molecular dynamics methods based on 536 NOE-derived restraints using DYANA software package (Guntert et al., 1997) . Among 200 calculated structures, the resulting best 50 ones were selected according to the lowest values of their target function. They were subjected to further procedures of minimization by Discover module of Insight II (MSI Molecular Simulations) using the DYANA derived restraints with a force constant value of 1. The inspection of the torsion angles according to the PROCHECK (Laskowski et al., 1996) software pointed out, for most of the calculated structures, the presence of two separate helical regions including residues 3 to 10 and 18 to 35. In Table 1 , the statistic of the structure calculation is reported.
Spin-Label Studies. The positioning of the peptide relative to the surface and interior of the SDS micelle was studied using the paramagnetic probes 5-and 16-doxyl stearic acids. Both compounds contain doxyl head groups, a cyclic nitroxide with unpaired electron, which is bound to the aliphatic chain carbon in position 5 or 16, respectively. These paramagnetic probes are expected to cause broadening of the NMR signals and decrease of resonance intensities from residues inside but close to the surface (5-doxyl) or deeply buried in the micelle (16-doxyl), respectively (Jarvet et al., 1997; Lindberg et al., 2001) .
TOCSY spectra of A42 in the presence and absence of the spin labels were recorded, keeping constant all other conditions. Just a few residues were affected by the presence of 5-doxylstearic acid. Particularly, Asp 21 and Met 29 NH/␣ signals nearly disappeared. On the other hand, the A42 spectrum, acquired in the presence of 16-doxyl stearic acid, evi- , and Leu 36 . B, electrostatic surface of the 3 to 10 ␣-helical fragment. The side chains defining clusters of hydrophobic (tryptophan) and hydrophilic residues are displayed and colored according to their hydrophobicity. Fig. 8 . Comparison of the conformational properties of the last 11 Cterminal residues of A42 (NMR structure in micellar solution) (blue) and the corresponding region of G␣ t derived from Koenig's model (orange) (Koenig et al., 2002) . The side chains of fragments are displayed and colored according to their hydrophobicity. , and Leu 37 were drastically affected by 16-doxylstearic acid, with a nearly disappearing of NH/␣ signals. These results provided strong evidences that A42 had a significant preference to be deeply buried in the micelles.
Discussion
The increasing knowledge of disease molecular basis has prompted the development of new classes of specific drugs such as peptide/polypeptide-or DNA-based drugs. Unfortunately, often these biomolecules show limited ability to cross the plasma membrane, resulting in poor cellular access, which largely prohibits them from reaching intracellular targets.
We developed previously a G␣ s 21-residue synthetic peptide that inhibits A 2A adenosine receptor-mediated activation of adenylyl cyclase in rat striatal membranes (Mazzoni et al., 2000) . Here, we created a cell-permeating version of such peptide by N-terminal modification with the cell-permeation sequence (16 residues) from the homeodomain of Antennapedia. Besides studying the biological activity and intracellular transfer of the cell-permeable G␣ s peptide, its structural properties were analyzed by NMR. This part of the work was a necessary step to confirm the ability of the G␣ s segment to acquire an ␣-helical conformation (Mazzoni et al., 2000) , even in the contest of a chimeric peptide. The ␣-helix structure of the 21-residue G␣ s peptide overlaps that of the G␣ s C terminus, shown by the crystal structure resolution (Sunahara et al., 1997) , and is pivotal for its biological activity (Mazzoni et al., 2000) . In addition, structural studies of the chimeric peptide in a membrane-mimicking environment are useful to elucidate the mechanism of penetratin internalization, an issue which is still debated (Richard et al., 2003) .
The Membrane-Permeable G␣ s Peptide Is an Inhibitor of Receptor-Stimulated cAMP Production in PC12 Cells and HMEC-1. The membrane-permeable G␣ s peptide (A42) did not affect cell viability but significantly inhibited adenosine receptor-mediated cAMP accumulation in PC12 cells, whereas the permeation sequence (A40) did not show any effect. These results prompted us to investigate the pharmacological profile of this inhibition by studying the concentration-dependent effect of the peptide. The A42 peptide was a potent inhibitor of cAMP accumulation in PC12 cells with an EC 50 value of approximately 5 M. The membrane-permeable peptide caused a dramatic decrease of agonist maximal efficacy. This effect was evident at a peptide concentration close to its EC 50 value. At higher peptide concentrations, NECA potency was also modulated. The observed reduction of NECA efficacy suggests that A42 competes with G␣ s for interaction with adenosine receptor, leading to a decreased number of activated G␣ s . The molecular basis supporting the decrease of NECA potency is less evident, but a shift of receptor affinity state for agonist ligands may be involved, as suggested by our previous observations (Mazzoni et al., 2000) . In contrast, to direct G␣ protein inhibitors such as suramin and analogs (Freissmuth et al., 1999) , the inhibition caused by A42 seems to be mixed competitive. Whereas suramin acts with several mechanisms in preventing receptor-mediated G protein activation, including suppression of spontaneous GDP-release from G␣ subunits and competition with receptors for binding to G proteins (Freissmuth et al., 1999) , our membrane-permeable G␣ s peptide does not directly modulate GDP/GTP exchange, but it competes with G␣ s for interacting with receptors. Thus, A42 decreasing the number of productive receptor G s interactions causes a reduction of agonist efficacy, whereas its binding to the receptor induces a decrease of receptor affinity for the agonist, which seems as reduction of agonist potency.
The A42 peptide did not directly modulate adenylyl cyclase activity and did not affect G i -and G q -coupled receptor signaling. Such observations are indicative that the specific peptide target is the receptor G s interface. Sequence alignment of G␣ s , G␣ i , and G␣ q C termini shows that the differences are restricted to a few key regions. However, these key residues are the structural determinants of receptor G␣ specificity of interaction . Our 21-residue G␣ s peptide was chosen on the basis of its ability to inhibit A 2A adenosine receptor-mediated production of cAMP in rat striatal membranes (Mazzoni et al., 2000) , whereas an 11-residue peptide was less effective. However, we must point out that because the A 2A adenosine receptor in rat striatum is coupled to G olf (Corvol et al., 2001) , we may have directed our selection toward a tool effective in disrupting their interaction. On the other hand, G olf shares extensive amino acid identity with G␣ s (Jones and Reed, 1989) , and divergences are not localized in the extreme C-terminal region. Others (Feldman et al., 2002) have shown that an 83-residue polypeptide derived from the C terminus of G␣ s specifically inhibits G s signaling in human embryonic kidney 293 cells. The A42 peptide was able to inhibit adenosine and ␤-adrenergic receptor-mediated cAMP production in a human cell line (HMEC-1), although with a lower effectiveness than in PC12 cells. This observation may indicate a certain selectivity of the peptide for inhibiting A 2A adenosine receptor coupling to G s proteins or may result as a consequence of the different ability of A42 to penetrate human endothelial cell plasma membrane.
The use of the carboxy-fluorescein-labeled A42 peptide proved to be a very effective strategy to verify peptide translocation inside of differentiated PC12 cells. Within 30 min, the A42 peptide is localized exclusively on plasma membrane, whereas later (3-6 h) is distributed between plasma membrane and cytoplasm. These results are particularly relevant because they are obtained in live cells and correlate the peptide localization on plasma membrane with its ability to inhibit adenosine receptor-mediated activation of the G s protein.
The use of membrane-permeable peptides to disrupt protein/protein interfaces and thus manipulate intracellular signaling pathways has attracted the interest of numerous investigators. Various peptides (cargo) have been successfully delivered inside cells through their conjugation to cell-penetrating peptides (carrier) such as pentratin (43-58) and transactivating regulatory protein (49-57) (Eiden, 2005) .
Two types of approaches have been used in the past to inhibit signaling from G s -coupled receptors in intact cells. Chang et al. (2000) successfully created a membrane-permeable G␣ s peptide by fusing with a chemical reaction the Kaposi fibroblast growth factor signal sequence to the N terminus of G␣ s , the last 11-residue fragment. On the other hand, Feldman et al. (2002) minigene encoding for a 83-residue polypeptide derived from the C terminus of G␣ s . Both approaches have produced interesting and useful results but also present some inconveniences that need improvement. In the case of the Kaposi fibroblast growth factor signal sequence-fused peptide, the G␣ s C-terminal sequence is rather short, and the membranepermeable peptide is obtained by using chemical oxidation followed by conjugation. The whole A42 peptide was synthesized by the conventional solid-phase strategy. On the other hand, the minigene approach cannot be suitable for all cell types.
NMR Analysis Reveals the ␣-Helical Conformation and Preference for a Hydrophobic Environment of the Membrane-Permeable G␣ s Peptide. Structural data support the interpretation of biological observations in the key of significant biomolecular interactions. Therefore, we undertook a full NMR investigation of the A42 peptide in membrane-mimetic environments to compare its structure with that of the 21-residue G␣ s peptide described previously (Mazzoni et al., 2000) . The choice of the membrane-like solvent was motivated on the fact that both the penetratin and the G␣ s segments are involved in membrane interactions.
NMR spectra were record in SDS and DPC micellar solutions, but data of the best quality were obtained in SDS micellar solutions. At a greater concentration than its critical micellar concentration (8 mM at 25°C), NMR experiments showed that A42 was arranged in two stretches of ␣-helical structure encompassing, respectively, residues 3 to 10 and 18 to 36. It is noticeable that even in a membrane-mimicking environment and in conjugation with a cell-penetrating peptide, the segment 18 to 36 can be well overlapped with the previously solved structure of the corresponding G␣ s (374-394)C 379 A peptide (D'Ursi et al., 2002) and even with the crystal structure of the G␣ s protein (Sunahara et al., 1997) . This demonstrates that the presence of the penetratin segment does not affect the conformational stability and functionality of the G␣ s (374-394)C 379 A peptide. The inspection of the electrostatic surface showed that the helix 18 to 36 was amphipathic (Fig. 7) (Fig. 7A) . Several studies attribute an important role to these amino acids as highly conserved residues directly involved in G protein receptor interaction (Kisselev et al., 1998) . In particular, it has been demonstrated by numerous biological evidences that a constant of the GPCR/G protein coupling is an electrostatic interaction involving highly conserved aspartic acid residues of G␣ C-terminal region with the highly conserved DRY motif of the receptors (Kisselev et al., 1998) . These contacts seem to be stabilized by multihelix interaction with C-terminal residues of the receptor involving several conserved hydrophobic residues such as Ile 383 and Leu 388 . It is interesting that the arrangement of the side chains of the 18 to 36 helix in A42, in particular those residues retained as important for the interaction with the cognate receptor (Kisselev et al., 1998) , was comparable with the orientation observed in the C-terminal G␣ t undecapeptide structure derived from the model of the G protein/receptor complex proposed by Koenig et al. (2002) (Fig. 8) . Thus, a consistency was evident between the models of the C-terminal G␣ helix, in the whole receptor/G protein complex and those of its related G␣ s (374-394)C 379 A peptide, even conjugated with a delivery molecule. There are sufficient data to believe that the conservation of these fundamental structural characters is responsible for the activity of the C-terminal peptide as that of the whole G␣ s protein.
TOCSY experiments of A42 in micelle solution, acquired alternatively, in the presence of 5-and 16-doxyl stearic acids, showed that the peptide was generally more sensitive to the action of 16-doxyl stearic acid, the inner core probe of the micelle. In particular, among the residues affected by 16-doxyl-stearic acid, four residues belonged to the C-terminal penetratin portion. These data supported the structural determinant of the penetratin delivery ability and showed that the conjugation of the penetratin peptide with a cargo did not affect the modality of its delivery functionality.
The distribution of the molecular surface of the penetratin segment compared with the G␣ s (374-394)C 379 A portion in A42 allows the formulation of a hypothesis on how the fine arrangement of the side chains can be related to the functionality of the biomolecule. Whereas the distribution of polar and hydrophobic residues defined an amphipathic ␣-helix in the G␣ s (374-394)C 379 A region, which seemed tailored to allow peptide key interactions with receptors, in the penetratin region, the distribution of the side chains is in such way to form clusters of hydrophobic and hydrophilic surfaces at the N terminus and in the center of the fragment, respectively (Fig. 7B) . The clustering of hydrophobic and hydrophilic residues is consistent with the most recent hypotheses, which re-establish the role of endocytosis in the internalization of cationic CPP (Richard et al., 2003) . The effect of the spin labels causes speculation on the A42 segment boundary that is inserted in the core of the micelle. In fact, the experiments in the presence of 5-doxyl stearic acid showed that only a few residues were localized in proximity of the micelle surface. In particular, residues 19 and 20 corresponding to the N-terminal region of the G␣ s (374-394)C 379 A portion were those significantly sensitive to the action of the surface probe of the micelle so that in a transport process, they can define the boundary between the region inserted in the membrane and that exposed on the surface.
In conclusion, our biological data, in conjugation with conformational analysis and fluorescence microscopy studies, indicate that the A42 peptide is a valuable, nontoxic research tool for modulating G s -coupled receptor signal transduction. These results represent the starting point for the development of new peptomimetic drug candidates acting at the intracellular level.
